UPLOAD Filing
CUMBERLAND PHARMACEUTICALS INC
Date: Aug. 25, 2025 · CIK: 0001087294 · Accession: 0000000000-25-009049
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-33637
Letter
Re: Cumberland Pharmaceuticals Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-33637 Dear John Hamm:
August 25, 2025
John Hamm Chief Financial Officer Cumberland Pharmaceuticals 1600 West End Avenue, Suite 1300 Nashville, TN 37203
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 25, 2025 John Hamm Chief Financial Officer Cumberland Pharmaceuticals 1600 West End Avenue, Suite 1300 Nashville, TN 37203 Re: Cumberland Pharmaceuticals Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-33637 Dear John Hamm: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>